Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
meet, Priyanka
NCT05539651: A Single and Multiple Ascending Doses Study to Evaluate the Safety and Pharmacokinetics of RBD5044	Completed	1	72	RoW	RBD5044, Placebo	Suzhou Ribo Life Science Co. Ltd.	Health Volunteer	10/24	10/24
NCT05653037: A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects	Active, not recruiting	1	32	RoW	RBD4059, Placebo	Suzhou Ribo Life Science Co. Ltd.	Healthy Volunteers	12/25	12/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
meet, Priyanka
NCT05539651: A Single and Multiple Ascending Doses Study to Evaluate the Safety and Pharmacokinetics of RBD5044	Completed	1	72	RoW	RBD5044, Placebo	Suzhou Ribo Life Science Co. Ltd.	Health Volunteer	10/24	10/24
NCT05653037: A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects	Active, not recruiting	1	32	RoW	RBD4059, Placebo	Suzhou Ribo Life Science Co. Ltd.	Healthy Volunteers	12/25	12/25